Christophe Arbet-Engels, MD, Q8: Most Effective Empagliflozin Dosing

Dr. Christophe Arbet-Engels explains how empagliflozin could be dosed once approved. and that the highest dose showed the most benefit in trials with reductions in weight and blood pressure.

Christophe Arbet-Engels, MD, PhD, MBA, is vice president, metabolic-clinical development and medical affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

See more SGLT-2 Resources